ELIZABETH BOECKMAN: Open Payments
NPI 1134753247 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 56 payments from 12 companies in 2025. Trend: 2023 $1,366 · 2024 $1,377 · 2025 $1,088
Food & beverage: $1,088
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $302 |
| Novartis Pharmaceuticals Corporation | 3 | $215 |
| Janssen Biotech, Inc. | 14 | $203 |
| Organon LLC | 5 | $78 |
| GENZYME CORPORATION | 3 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $39 |
| Amgen Inc. | 2 | $35 |
| LEO Pharma Inc. | 1 | $30 |
| Incyte Corporation | 1 | $26 |
Products named: SKYRIZI, TREMFYA, DUPIXENT, Rhapsido, RINVOQ, VTAMA, OTEZLA, ADBRY.
Industry payments across IA — which companies pay providers there.
